Vázquez-Lorente Héctor, García-Gavilán Jesús F, Shyam Sangeetha, Konieczna Jadwiga, Martínez J Alfredo, Martín-Sánchez Vicente, Fitó Montserrat, Ruiz-Canela Miguel, Paz-Graniel Indira, Curto Ariadna, Martinez-Urbistondo Diego, de Paz Fernández José Antonio, Romaguera Dora, Babio Nancy, Salas-Salvadó Jordi
ANUT-DSM (Alimentaciò, Nutrició Desenvolupament i Salut Mental), Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Reus, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición, Institute of Health Carlos III, Madrid, Spain.
JAMA Netw Open. 2025 Apr 1;8(4):e253710. doi: 10.1001/jamanetworkopen.2025.3710.
Understanding the effects of diet and physical activity on bone health may help to mitigate concomitant weight loss- and age-related bone deterioration.
To evaluate the effects of a weight-loss lifestyle intervention on bone mineral density (BMD), bone mineral content (BMC), and low BMD prevalence.
DESIGN, SETTING, AND PARTICIPANTS: The 3-year, parallel-group Prevención con Dieta Mediterránea-Plus (PREDIMED-Plus) randomized clinical trial was conducted at recruiting centers in Spain from October 2013 to December 2016. Men and women (aged 55-75 years) with metabolic syndrome and overweight or obesity, as well as access to dual-energy x-ray absorptiometry (DXA) (from 4 centers in Navarra, Mallorca, Reus, and León), were included in this prespecified secondary analysis. The analysis was conducted from September 1 to October 30, 2024.
Participants were randomly allocated (1:1) to the intervention or the control. The intervention group followed an energy-reduced Mediterranean diet and increased physical activity, whereas the control group was advised to follow an ad libitum Mediterranean diet with no physical activity promotion.
BMD (total femur, lumbar spine [L1-L4], and femoral trochanter) and total BMC were measured using DXA at baseline and at 1 and 3 years of follow-up. T scores from BMD variables were determined, and osteopenia or osteoporosis status was defined as low BMD. Linear and logistic 2-level mixed models were used for main analyses including participants lost to follow-up. Intention-to-treat analysis, completers case analysis, and sensitivity analysis were additionally performed.
This study included 924 older adults (mean [SD] age, 65.1 [5.0] years; 454 women [49.1%] and 470 men [50.9%]). Significant differences in mean changes between groups were observed, with an overall 3-year intervention increase in the intervention group (n = 460) compared with the control group (n = 464) in lumbar spine (L1-L4) BMD (between-group differences, -0.1 [95% CI, -0.8 to 0.8] g/cm2 after 1 year and 0.9 [95% CI, 0.1-1.8] g/cm2 after 3 years; overall P = .05). This protective association was observed for women (between-group differences, -0.1 [95% CI, -1.3 to 1.1] g/cm2 after 1 year and 1.8 [95% CI, 0.6-2.9] g/cm2 after 3 years; overall P = .005) but not for men. No overall 3-year intervention effect on total BMC and low BMD prevalence was observed.
In the PREDIMED-Plus trial, an energy-reduced Mediterranean diet and physical activity lifestyle intervention mitigated weight loss- and age-related BMD decline among older women with metabolic syndrome compared with conventional ad libitum Mediterranean diet recommendations. Weight-loss lifestyle interventions with longer follow-up are warranted in the future to confirm these results in relation to bone health.
ISRCTN Registry Identifier: ISRCTN89898870.
了解饮食和体育活动对骨骼健康的影响,可能有助于减轻伴随体重减轻和年龄增长而出现的骨骼退化。
评估减肥生活方式干预对骨密度(BMD)、骨矿物质含量(BMC)和低骨密度患病率的影响。
设计、地点和参与者:为期3年的平行组地中海饮食预防加运动(PREDIMED-Plus)随机临床试验于2013年10月至2016年12月在西班牙的招募中心进行。纳入了患有代谢综合征且超重或肥胖、可进行双能X线吸收测定(DXA)(来自纳瓦拉、马略卡、雷乌斯和莱昂的4个中心)的55至75岁男性和女性,进行这项预先设定的二次分析。分析于2024年9月1日至10月30日进行。
参与者被随机分配(1:1)至干预组或对照组。干预组遵循能量减少的地中海饮食并增加体育活动,而对照组则被建议随意遵循地中海饮食且不提倡体育活动。
在基线以及随访1年和3年时,使用DXA测量BMD(全股骨、腰椎[L1-L4]和股骨粗隆)和总BMC。确定BMD变量的T值,并将骨量减少或骨质疏松状态定义为低骨密度。主要分析采用线性和逻辑二级混合模型,纳入失访参与者。此外还进行了意向性分析、完成者病例分析和敏感性分析。
本研究纳入了924名老年人(平均[标准差]年龄为65.1[5.0]岁;454名女性[49.1%]和470名男性[50.9%])。观察到两组之间平均变化存在显著差异,与对照组(n = 464)相比,干预组(n = 460)在3年的干预期内腰椎(L1-L4)BMD总体增加(组间差异,1年后为-0.1[95%置信区间,-0.8至0.8]g/cm²,3年后为0.9[95%置信区间,0.1 - 1.8]g/cm²;总体P = 0.05)。在女性中观察到这种保护关联(组间差异,1年后为-0.1[95%置信区间,-1.3至1.1]g/cm²,3年后为1.8[95%置信区间,0.6 - 2.9]g/cm²;总体P = 0.005),但在男性中未观察到。未观察到3年干预对总BMC和低骨密度患病率的总体影响。
在PREDIMED-Plus试验中,与传统的随意地中海饮食建议相比,能量减少的地中海饮食和体育活动生活方式干预减轻了患有代谢综合征的老年女性体重减轻和年龄相关的BMD下降。未来有必要进行更长随访期的减肥生活方式干预,以确认这些与骨骼健康相关的结果。
ISRCTN注册标识符:ISRCTN89898870。